INVASIVE PNEUMOCOCCAL INFECTION

Clinical trials for INVASIVE PNEUMOCOCCAL INFECTION explained in plain language.

Never miss a new study

Get alerted when new INVASIVE PNEUMOCOCCAL INFECTION trials appear

Sign up with your email to follow new studies for INVASIVE PNEUMOCOCCAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Boosting defenses: can extra vaccine doses protect vulnerable patients?

Prevention Completed

This study tested whether giving stronger or extra doses of pneumonia vaccines could better protect patients with a rare autoimmune disease (ANCA-associated vasculitis) who are taking a drug called rituximab. Rituximab weakens the immune system, making these patients more prone t…

Matched conditions: INVASIVE PNEUMOCOCCAL INFECTION

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention

Last updated Mar 12, 2026 13:51 UTC

INVASIVE PNEUMOCOCCAL INFECTION

Get alerted when new INVASIVE PNEUMOCOCCAL INFECTION trials appear

Boosting defenses: can extra vaccine doses protect vulnerable patients?